| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Mrz―10 |
NLRC5/MHC class I transactivator: A key target for immune escape by SARS-CoV-2 |
Baohui Zhu, Ryota Ouda, Yusuke Kasuga, Paul de Figueiredo, Koichi S. Kobayashi |
| 2 |
[GO] |
2023―Jun―10 |
Jerne's “immune network theory”, of interacting anti-idiotypic antibodies applied to immune responses during COVID-19 infection and after COVID-19 vaccination |
Sven Kurbel |
| 3 |
[GO] |
2022―Jul―18 |
Molecular dynamics studies reveal structural and functional features of the SARS-CoV-2 spike protein |
Ludovico Pipitò, Roxana-Maria Rujan, Christopher A. Reynolds, Giuseppe Deganutti |
| 4 |
[GO] |
2021―Nov―23 |
The SARS-CoV-2 origin dilemma: Zoonotic transfer or laboratory leak? |
Blanca E. Ruiz-Medina, Armando Varela-Ramirez, Robert A. Kirken, Elisa Robles-Escajeda |
| 5 |
[GO] |
2021―Okt―26 |
There is still no evidence of SARS-CoV-2 laboratory origin: Response to Segreto and Deigin (10.1002/bies.202100137) |
Alexander Tyshkovskiy, Alexander Y. Panchin |
| 6 |
[GO] |
2021―Jul―30 |
The genetic structure of SARS-CoV-2 is consistent with both natural or laboratory origin: Response to Tyshkovskiy and Panchin (10.1002/bies.202000325) |
Yuri Deigin, Rossana Segreto |
| 7 |
[GO] |
2021―Jul―26 |
Personalized health and the coronavirus vaccines-Do individual genetics matter? |
Bianca N. Valdés-Fernández, Jorge Duconge, Ana M. Espino, Gualberto Ruaño |
| 8 |
[GO] |
2021―Jul―02 |
Does chronic inflammation cause acute inflammation to spiral into hyper-inflammation in a manner modulated by diet and the gut microbiome, in severe Covid-19? |
Manni Luthra-Guptasarma, Purnananda Guptasarma |
| 9 |
[GO] |
2021―Jun―09 |
Air pollution and cardiovascular disease: Can the Australian bushfires and global COVID-19 pandemic of 2020 convince us to change our ways? |
Kathryn Wolhuter, Manish Arora, Jason C. Kovacic |
| 10 |
[GO] |
2021―Jun―04 |
SARS-CoV-2 infection and cancer |
Aureliano Stingi, Luca Cirillo |
| 11 |
[GO] |
2021―Mai―28 |
SARS-CoV-2′s claimed natural origin is undermined by issues with genome sequences of its relative strains |
Yuri Deigin, Rossana Segreto |
| 12 |
[GO] |
2021―Apr―29 |
Cancer as a prospective sequela of long COVID-19 |
Geetanjali Saini, Ritu Aneja |
| 13 |
[GO] |
2021―Apr―16 |
Can ketone bodies inactivate coronavirus spike protein? The potential of biocidal agents against SARS-CoV-2 |
Alaa Shaheen |
| 14 |
[GO] |
2021―Apr―07 |
Two leading international congresses in Iran in the era of COVID-19: 21st royan international twin congress, 4th international and 16th Iranian genetics congress |
Leila Montazeri, Maryam Mohajeri, Hossein Baharvand, Rouhollah Fathi, Valeria Poli, Sara Kazemi, et al. (+4) Fattaneh Pahlavan, Solmaz Kouhestani, Firoozeh Ahmadi, Seyed Javad Mowla |
| 15 |
[GO] |
2021―Mrz―10 |
There is no evidence of SARS-CoV-2 laboratory origin: Response to Segreto and Deigin (https://doi.org/10.1002/bies.202000240) |
Alexander Tyshkovskiy, Alexander Y. Panchin |
| 16 |
[GO] |
2021―Feb―20 |
The cost of superficial values in a life-threatening pandemic: How globalization grates against evolution… |
Andrew Moore |
| 17 |
[GO] |
2020―Dez―30 |
Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera |
Constantin Pape, Roman Remme, Adrian Wolny, Sylvia Olberg, Steffen Wolf, Lorenzo Cerrone, et al. (+21) Mirko Cortese, Severina Klaus, Bojana Lucic, Stephanie Ullrich, Maria Anders-Össwein, Stefanie Wolf, Berati Cerikan, Christopher J. Neufeldt, Markus Ganter, Paul Schnitzler, Uta Merle, Marina Lusic, Steeve Boulant, Megan Stanifer, Ralf Bartenschlager, Fred A. Hamprecht, Anna Kreshuk, Christian Tischer, Hans-Georg Kräusslich, Barbara Müller, Vibor Laketa |
| 18 |
[GO] |
2020―Dez―18 |
The renin-angiotensin system in COVID-19: Why ACE2 targeting by coronaviruses produces higher mortality in elderly hypertensive patients? |
Sven Kurbel |
| 19 |
[GO] |
2020―Nov―20 |
Strangers look sicker (with implications in times of COVID-19) |
Paola Bressan |
| 20 |
[GO] |
2020―Nov―17 |
The genetic structure of SARS-CoV-2 does not rule out a laboratory origin |
Rossana Segreto, Yuri Deigin |
| 21 |
[GO] |
2020―Nov―11 |
Why does COVID-19 pathology have several clinical forms? |
Fatemeh Aliabadi, Marjan Ajami, Hamidreza Pazoki-Toroudi |
| 22 |
[GO] |
2020―Nov―10 |
Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis? |
Preetam Basak, Naresh Sachdeva, Devi Dayal |
| 23 |
[GO] |
2020―Nov―09 |
Can immunological manipulation defeat SARS-CoV-2? Why G-CSF induced neutrophil expansion is worth a clinical trial |
Hiroshi Katayama |
| 24 |
[GO] |
2020―Okt―11 |
Superposition of COVID-19 waves, anticipating a sustained wave, and lessons for the future |
Joel Weijia Lai, Kang Hao Cheong |
| 25 |
[GO] |
2020―Sep―22 |
Repurposing Vaccines in the Fight against COVID-19 |
Kang Hao Cheong |
| 26 |
[GO] |
2020―Sep―01 |
Age and Location in Severity of COVID-19 Pathology: Do Lactoferrin and Pneumococcal Vaccination Explain Low Infant Mortality and Regional Differences? |
Robert Root-Bernstein |
| 27 |
[GO] |
2020―Aug―28 |
Beta-adrenergic Blockers as a Potential Treatment for COVID-19 Patients |
Natesan Vasanthakumar |
| 28 |
[GO] |
2020―Aug―12 |
Might SARS-CoV-2 Have Arisen via Serial Passage through an Animal Host or Cell Culture? |
Karl Sirotkin, Dan Sirotkin |
